FAM
GHDX

Fred Alger Management’s Genomic Health, Inc. GHDX Stock Holding History

Fred Alger Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,000
Closed -$140K – 597
2018
Q3 		$140K Buy
+2,000
New +$117K ﹤0.01% 392
2015
Q3 		– Sell
-16,300
Closed -$453K – 521
2015
Q2 		$453K Buy
+16,300
New +$460K ﹤0.01% 474

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fred Alger Management's GHDX Position: Q4 2018 in Review

Fred Alger Management sold out of Genomic Health, Inc. (GHDX) in Q4 2018, closing a stake of 2,000 shares — an estimated $140K sold.

Fred Alger Management first reported a position in GHDX in Q2 2015 and held it in 2 quarters. The position peaked at $453K in Q2 2015. 228 funds tracked by Wall St. Rank hold GHDX as of Q4 2018.

  • Fred Alger Management reported no remaining Genomic Health, Inc. position as of Q4 2018 after selling out during the quarter.
  • Fred Alger Management sold 2,000 Genomic Health, Inc. shares in Q4 2018, an estimated $140K.
  • Fred Alger Management first reported a position in Genomic Health, Inc. in Q2 2015 and held it in 2 quarters.
  • Fred Alger Management's Genomic Health, Inc. position peaked at $453K in Q2 2015.
  • 228 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2018.

Based on Fred Alger Management's 13F filing for Q4 2018, filed 14 Feb 2019.